03.19.26 -- The Cost Of Transactional Thinking In Clinical Research

Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.

Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.

Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.

Targeted modalities are pushing the boundaries of technology, and their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

From site selection to data management and regulatory guidance, Altasciences' experts orchestrate every aspect of your clinical programs. Expect quality, speed, and seamless collaboration at every step.

Sophia McLeod, an advocacy advisor at ACRO, explains ACRO's concerns about FDA staffing losses. She also talks about the effects of "policy by press release" rather than traditional notice-and-comment periods.

Navigate ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

The Clinical Trials Regulation and its centralized digital platform, the Clinical Trials Information System (CTIS), are now mandatory. Are you prepared to navigate your next clinical trial in the EU?

Explore how the guide for eRegulatory adoption in Canada provides resources to help stakeholders navigate these changes and enhance participant engagement and retention in clinical trials.